Patents by Inventor Sabine PROHL

Sabine PROHL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170071869
    Abstract: The subject invention provides an oral patch comprising: a) a liner; and b) a film composition thereon, the film composition comprising (i) laquinimod in an amount of about 0.1%-20% by weight of the film composition, and (ii) one or more film forming agents in a total amount of about 40%-90% by weight of the film composition. The subject invention also provides a method for delivering laquinimod across the oral mucosa of a subject, or for treating a human subject afflicted with a form of multiple sclerosis, comprising periodically administering to the human subject an oral patch as described herein. The subject invention also provides an oral patch as described herein for use in treating a human subject afflicted with a form of multiple sclerosis.
    Type: Application
    Filed: March 13, 2015
    Publication date: March 16, 2017
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ralph Stefan, Hans Juergen Mika, Claudia Lauer, Dirk Schenk, Sabine Prohl
  • Patent number: 9480655
    Abstract: The present invention relates to a solid pharmaceutical dosage form comprising dolutegravir, a method of its preparation and its use in the treatment of an HIV infection.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: November 1, 2016
    Assignee: ratiopharm GmbH
    Inventors: Dominique Meergans, Sabine Prohl, Hans Juergen Mika
  • Publication number: 20160038435
    Abstract: This invention provides a transdermal patch comprising a) a backing layer; b) a liner; c) optionally, a highly porous membrane; and d) a pharmaceutical composition comprising: (i) optionally, a pressure sensitive adhesive in an amount of up to about 95 wt % of the pharmaceutical composition, (ii) laquinimod in an amount of about 0.1-20 wt % of the pharmaceutical composition, and (iii) optionally, one or more permeation enhancers in a total amount of up to about 70 wt % of the pharmaceutical composition. This invention also provides a method for delivering laquinimod across the skin of the subject and for treating a human subject afflicted with a form of multiple sclerosis comprising administering to the skin of the subject a transdermal patch as described herein. This invention further provides a transdermal patch as described herein for use in treating a human subject afflicted with a form of multiple sclerosis.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 11, 2016
    Applicant: Teva Pharmaceutical Industries Ltd.
    Inventors: Ralph STEFAN, Hans-Juergen MIKA, Tanja PRIES, Dirk SCHENK, Sabine PROHL
  • Publication number: 20160030353
    Abstract: The present invention relates to a solid pharmaceutical dosage form comprising dolutegravir, a method of its preparation and its use in the treatment of an HIV infection.
    Type: Application
    Filed: February 18, 2014
    Publication date: February 4, 2016
    Applicant: ratiopharm GmbH
    Inventors: Dominique MEERGANS, Sabine PROHL, Hans Juergen MIKA
  • Publication number: 20160022661
    Abstract: The invention relates to a method of preparing a tablet, preferably a tablet for immediate release and having a high drug load, containing crizotinib in form of the free base and lubricant, both in specific amounts. The invention further relates to a tablet obtainable by said method.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Ralph STEFAN, Sabine PROHL